Skip to main content
BVS
NASDAQ Life Sciences

Bioventus Beats on Margins, Trims Sales Guidance as Strategic Review Continues

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$13.15
Mkt Cap
$1.106B
52W Low
$6.47
52W High
$15.893
52W Position info
103% above low
Off High info
17% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

BVS has more than doubled off its 52-week low of $6.47.

Summary

Bioventus posted Q3 revenue of $142.4 million, up 2.7% year over year, with net income attributable to the company of $6.0 million versus $3.2 million a year ago. Adjusted EBITDA rose 7% to $28.4 million on a 74.7% non-GAAP gross margin, and non-GAAP EPS of $0.17 beat last year's $0.15. The company also made a $15.0 million discretionary principal prepayment on its term loan, cutting interest expense to $3.8 million from $6.2 million. The blemish is the top line: full-year net sales guidance was trimmed to $590-$595 million (roughly 4-5% growth), while Adjusted EPS guidance of $0.75-$0.79 was reaffirmed. Management said the strategic alternatives review — launched after an unsolicited acquisition proposal — is ongoing, and $3.6 million of related costs hit the quarter.

At the time of this announcement, BVS was trading at $13.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $6.47 to $15.89. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BVS - Latest Insights

BVS
Nov 02, 2026, 4:20 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.02
Real-time Price: $10.73 info
Change: -$0.2952 (-3%) info
Market Cap: $903.699M info
BVS
Aug 05, 2026, 7:43 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $12.12
Real-time Price: $10.73 info
Change: -$1.39 (-12%) info
Market Cap: $903.699M info
BVS
Aug 05, 2026, 7:41 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.21
Real-time Price: $10.73 info
Change: -$0.485 (-4%) info
Market Cap: $903.699M info
BVS
Aug 05, 2026, 7:40 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $12.13
Real-time Price: $10.73 info
Change: -$1.41 (-12%) info
Market Cap: $903.699M info
BVS
Jul 03, 2026, 12:24 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $10.88
Real-time Price: $10.73 info
Change: -$0.155 (-1%) info
Market Cap: $903.699M info